Replies to post #32374 on Ariad Pharmaceuticals Inc fka ARIA

[jaybe]

This study makes EGFR/FGFR combo even more clear....

Missed this one from March 2013.

http://www.nature.com/oncsis/journal/v2/n3/full/oncsis20134a.html

"...we suggest that treatment with combinations of EGFR and FGFR inhibitors may be superior to sequential treatment with an FGFR inhibitor."


Keep an eye on this Phase 1 trial by Novartis/ Genentech(Roche)combining gefitinib and dovitinib, results by end of year.

http://clinicaltrials.gov/show/NCT01515969